The COVID-19 vaccines offered in Europe today have been approved by regulators including the European Medicines Agency. The vaccines are tested for safety in humans during development and are therefore only approved if safety is proven in most people, including those living with HIV.
Before vaccines are licensed for scale-up, national regulatory authorities assess the results and ensure that they are safe. No data have emerged to suggest that people living with HIV are at greater risk from the COVID-19 vaccines than anyone else.
The approved vaccines contain some of the proteins present on the SARS-CoV-2 virus (the virus that causes COVID-19). These proteins will be recognised by our body, which reacts by developing antibodies. None of the vaccines being developed against COVID-19 contain live viruses, which makes them equally safe in people with compromised immune systems. Therefore, people with HIV are not at increased risk of safety when vaccinated.
Translated from Dutch with www.DeepL.com/Translator (free version), source https://www.unaids.org/sites/default/files/media_asset/covid19-vaccines-and-hiv_en.pdf, consulted on 08/02/2021